Radiotherapy Devices Market Report 2026

Radiotherapy Devices Market Overview

• Radiotherapy Devices market size has reached to $6.64 billion in 2025 • Expected to grow to $10.18 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Rising Cancer Prevalence Drives Demand For Radiotherapy Devices • Market Trend: Innovative Technologies Transforming The Radiotherapy Devices Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Radiotherapy Devices Market?

Radiotherapy devices are used in cancer treatment by using high doses of radiation to kill cancer cells and shrink tumors. They are used to destroy cancerous cells and shrink tumors while minimizing damage to surrounding healthy tissue. By employing various techniques, such as external beam radiation and brachytherapy, these devices play a crucial role in cancer treatment and management. The main product type of radiotherapy devices is external beam radiation therapy devices, linear accelerator devices, and proton therapy devices. A medical linear accelerator (LINAC) is a radiotherapy device that is generally utilized for external beam radiation treatments for patients with cancer. It supplies high-energy x-rays or electrons to the region of the patient's tumor. The applications are skin cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others. These are used in hospitals, ambulatory surgical centres, and oncological treatment centres.

What Is The Radiotherapy Devices Market Growth Forecast?

The radiotherapy devices market size is expected to see strong growth in the next few years. It will grow to $10.18 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to growing demand for personalized cancer treatment, increasing investments in proton therapy centers, expansion of AI-assisted oncology workflows, rising focus on minimizing radiation side effects, continued technological innovation in radiation delivery systems. Major trends in the forecast period include increasing adoption of image-guided radiation therapy systems, rising deployment of proton therapy technologies, growing integration of ai-based treatment planning, expansion of stereotactic radiation techniques, enhanced focus on precision dose delivery.

Global Radiotherapy Devices Market Segmentation

1) By Product Type: External Beam Radiation Therapy Devices, Linear Accelerator Devices, Proton Therapy Devices 2) By Application: Skin Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Other Applications 3) By End Users: Hospitals, Ambulatory Surgical Centers, Oncological Treatment Centers Subsegments: 1) By External Beam Radiation Therapy Devices: Intensity-Modulated Radiation Therapy (IMRT) Devices, Image-Guided Radiation Therapy (IGRT) Devices, Stereotactic Body Radiation Therapy (SBRT) Devices, Stereotactic Radiosurgery (SRS) Devices, 3D Conformal Radiation Therapy (3D CRT) Devices 2) By Linear Accelerator Devices: Conventional Linear Accelerators, Stereotactic Linear Accelerators 3) By Proton Therapy Devices: Cyclotron-Based Devices, Synchrotron-Based Devices, Synchrocyclotron-Based Devices

What Is The Driver Of The Radiotherapy Devices Market?

The increasing cancer prevalence is expected to propel the growth of the radiotherapy devices market going forward. Cancer prevalence refers to the total number or percentage of individuals in a population who have been diagnosed with cancer at a particular point in time or over a specific period. Radiotherapy is commonly used as a primary or adjunctive treatment for cancer patients who have been newly diagnosed. It is often employed to shrink tumors, control cancer growth, or eliminate cancer cells before or after surgery. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia the number of cancer cases diagnosed increased from 160,570 in 2022 to 164,694 in 2023, reflecting a notable rise over the year. This upward trend highlights the growing prevalence of cancer within the country. Therefore, the increasing cancer prevalence is driving the growth of the radiotherapy devices industry.

Key Players In The Global Radiotherapy Devices Market

Major companies operating in the radiotherapy devices market are Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Eckert & Ziegler Bebig, IsoRay Inc., General Electric Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corporation, Canon Medical Systems Corporation, Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, Neusoft Medical Systems Co. Ltd., Mevion Medical Systems Inc., Optivus Proton Therapy Inc., Panacea Medical Technologies Pvt. Ltd., P-Cure Ltd., Provision Healthcare LLC, Sumitomo Heavy Industries Ltd., ViewRay Inc., Miranda Medical, Nordion Inc., NTP Radioisotopes SOC Ltd., Curium, Hitachi Ltd., Brainlab AG, Best Theratronics Ltd., ProTom International Inc., RefleXion Medical Inc., Insightec Ltd., TomoTherapy Incorporated, Agile MV LLC, CIVCO Radiotherapy, Johari Digital Healthcare Ltd., Alpha Tau Medical Ltd.,

Global Radiotherapy Devices Market Trends and Insights

Major companies operating in the radiotherapy devices market are innovating new technologies such as The Versa HD to increase their profitability in the market. The Versa HD is a linear accelerator system for radiation therapy. For instance, in May 2023, Mitchell Cancer Institute, a US-based cancer treatment centre launched new radiation technology called The Versa HD. The Versa HD can administer Volumetric Modulated Arc Therapy (VMAT), which expedites the delivery of treatments and enhances the patient experience. High-Definition Dynamic Radiosurgery (HDRS), which has special sequencing capabilities and converts the linac into a specialized SRS solution, is a service that the Versa HD is capable of providing.

What Are Latest Mergers And Acquisitions In The Radiotherapy Devices Market?

In October 2023, Elekta, a Sweden-based provider of radiotherapy devices and oncology treatment solutions, acquired Xoft Axxent electronic brachytherapy (eBx) system from iCAD, Inc. for US$ 5.5 million. With this acquisition, Elekta aimed to expand its brachytherapy portfolio and scale the adoption of electronic X-ray-based brachytherapy systems in markets with limited radiation shielding infrastructure. iCAD, Inc. is a US-basedcompany that manufactures radiotherapy devices.

Regional Outlook

North America was the largest region in the radiotherapy devices market in 2025. Asia-Pacific was the second-largest region in the global radiotherapy devices market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

What Defines the Radiotherapy Devices Market?

The radiotherapy devices market consists of sales of external beam radiation therapy devices, linear accelerator devices, and proton therapy devices that are used for radiotherapy. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.